Elixirs, Drops, Powders, and Pills: The Origins and Foundation of the American Patent Medicine Industry by Tharp, Brent W.
W&M ScholarWorks 
Dissertations, Theses, and Masters Projects Theses, Dissertations, & Master Projects 
1988 
Elixirs, Drops, Powders, and Pills: The Origins and Foundation of 
the American Patent Medicine Industry 
Brent W. Tharp 
College of William & Mary - Arts & Sciences 
Follow this and additional works at: https://scholarworks.wm.edu/etd 
 Part of the Pharmacy and Pharmaceutical Sciences Commons, and the United States History 
Commons 
Recommended Citation 
Tharp, Brent W., "Elixirs, Drops, Powders, and Pills: The Origins and Foundation of the American Patent 
Medicine Industry" (1988). Dissertations, Theses, and Masters Projects. Paper 1539625478. 
https://dx.doi.org/doi:10.21220/s2-40j5-0g42 
This Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M 
ScholarWorks. It has been accepted for inclusion in Dissertations, Theses, and Masters Projects by an authorized 
administrator of W&M ScholarWorks. For more information, please contact scholarworks@wm.edu. 
ELIXIRS, DROPS, POWDERS, AND PILLS:
The Origins and Foundation of the American 
Patent Medicine Industry
A Thesis 
Presented to 
The- Faculty of the Department of History 
The College of William and Mary in Virginia
In Partial Fulfillment 
Of the Requirements for the Degree of 
Master of Arts
by
Brent W. Tharp 
1988
APPROVAL SHEET
This thesis is submitted in partial fulfillment of 
the requirements for the degree of
Master of Arts
^ ^ 3: Uj. "71
Author
Approved, May 1988
______  Au*, A&dUL
James L. Axtell
Achievement stands on 
the best of friends. This 
their support, advice, and 
poss ible.
a foundation of close family and 
thesis is dedicated to them for 
encouragement, which made it
i i i
TABLE OF CONTENTS
Page
ACKNOWLEDGEMENTS................................................. V
INTRODUCTION...................................................... 2
CHAPTER I. THE ORIGINS OF THE PATENT MEDICINE INDUSTRY.... 7
CHAPTER II. THE DEVELOPMENT OF THE AMERICAN MARKET........24
CHAPTER III. THE DEVELOPMENT OF THE AMERICAN INDUSTRY.... 43
APPENDIX A ....................................................... 63
APPENDIX B ............................  66
BIBLIOGRAPHY.................................................... .69
iv
ACKNOWLEDGEMENTS
The writer wishes to express his appreciation to 
Professor James Axtell under whose guidance this 
investigation was conducted, and to Professors Kevin Kelly 
and John Selby for their time and effort in carefully 
reading this manuscript.
v
ABSTRACT
The purpose of this study is to trace the origins and 
development of the patent medicine industry in America from 
its beginnings in the late seventeenth century to the early 
nineteenth century.
The origins of the patent medicine industry lie in 
centuries of folk medicine. Traditionally used as family 
remedies, these ancient remedies were first produced on a 
large scale and marketed outside their local regions in the 
late-seventeenth and early-eighteenth centuries.
Patent medicines were imported to America in great 
quantities by the middle of the eighteenth century. The 
colonies were almost entirely dependent upon England for 
supplies of patent medicines. The Revolution, however, cut 
off these supplies, and forced Americans to produce their 
o w n .
English patent medicines returned to America after the 
war, but they could not compete with the American industry 
the war had created. American entrepreneurial efforts in 
the patent medicine industry continued to expand, guided by 
their English origins.
ELIXIRS, DROPS, POWDERS, AND PILLS:
THE ORIGINS AND FOUNDATION OF THE AMERICAN 
PATENT MEDICINE INDUSTRY
INTRODUCTION
The mention of patent medicines evokes images of the 
nineteenth-century salesman peddling his wares from the back 
of a colorful wagon, providing showmanship and song to draw 
his unsuspecting crowd. Once they had gathered, the 
entertainment ceased and business began. An American social 
commentator of the 1850's in his pamphlet Humbug; A Look At 
Some Popular Impositions satirized these cunning vendors 
with ironic accuracy:
"Congratulate me —  my fortune is made -- I am 
immortalized, and I've done it myself. I have gone 
into the Patent Medicine business... Bought a gallon 
of tar, a cake of beeswax, and a firkin of lard, and 
in twenty-one hours I presented to the world the first 
batch of Doestick's Patent Self-Acting-Four-Horse­
power Balsam, designed to cure all diseases of mind, 
body, or estate, to give strength to the weak, money 
to the poor, bread and butter to the hungry, boots to 
the bare-foot, decency to blackguards, and common 
sense to the Know-Nothings. It acts physically, 
morally, mentally, psychologically, physiologically, 
and geologically; and it is intended to make our 
sublunary sphere a blissful paradjse, to which itself 
Heaven shall be but a side-show."
This was a time of bawdy and gaudy salesmanship with 
no bounds. It was truly "anything goes." One English 
advertiser was so bold as to donate hymnals to a poor parish 
with the lyrics:
"Hark the herald angels sing 
Beecham's Pills are just the thing. 
For blessed peace and mercy --
Two for Mother, one for child!"
2
3Americans knew the business as well, and were just as adept
at marketing as their English competitors. The situation in
America led the anonymous commentator to reflect that, "the
people of this Yankee-land have acquired a world-wide
reputation of being unapproachably 'cute' and 'sharp;' and
they, no doubt, have earned the reputation; yet it is
notorious there is no people over whose eyes it is so east
to 'pull the wool,' —  so easy to dupe and humbug, as this
same 'cute Yankee people...Our 'cute brethren take as
naturally to mermaids, woolly horses, and humbugs generally,
as ducks to a millpond. Were this not the case, Yankeedom
3
would not be what it now is, -- the Paradise of Quacks."
Paradise is a good choice of words for the situation in 
nineteenth-century America. Medical knowledge was still 
limited and government regulation of the field was almost 
nonexistent. There was, thus, a great market for nostrums 
and no practical restrictions on their manufacture or sale. 
In fact, the only government involvement in the patent 
medicine business, until the Pure Food and Drug Act of 1906, 
was its attempt to reap some profit through the patent 
medicine stamp tax. Under these unrestricting 
circumstances, medical nostrums became a gigantic industry.
Patent medicines are still a gigantic industry. A 
recent House Subcommittee on Health and Long-term Care 
estimated medical quackery to be a $10 billion business in
4
the U.S. and growing "at an alarming rate." In spite of 
all our present medical knowledge and our strict regulation,
4patent medicines are still a booming business. Many of the 
reasons for its success remain the same as they were in the 
industry's infancy in the eighteenth century.
The names may have changed over 200 years, but there
remain diseases for which there is no known cure. Yet
people have always hoped miracle cures would be derived from
a yet unknown source. In the eighteenth century that hope
spurred people to ingest a concoction known as Turlington's
Balsam. Distilled from the bark and roots of several South
American plants, Turlington's Balsam claimed to cure malaria
or the ague, as it was often called. In the twentieth
century, that same hope has spurred people to spend their
money on another concoction made from the bark of a South
American tree. Pau D'Arco Taheebo Tea, produced by the
Nutrition for Life company, "works with the immune system"
said one distributor, and can therefore, she claims, cure
5
cancer and AIDS.
Patent medicines have always been popular as the 
quick and easy path to good health and beauty. * Women in the 
eighteenth century, desiring porcelain-like, white 
complexions, dosed themselves with various arsenic and lead- 
based nostrums, which were fatal with continuous use. 
Similarly, vanity in the twentieth century has created a 
vast market for quick diet nostrums. The Herbalife Company 
produces several diet products based on powerful herbal 
laxatives that medical consultants agree can cause 
dependency and mineral depletion.
5The sustaining factor of the industry has, from the 
eighteenth century on, been advertising. It was the 
increased availability of newspaper advertising space that 
was the growth catalyst for the industry in the eighteenth 
century. It turned local reputations and remedies into 
international celebrities and merchandising fortunes. The 
tactics of testimonial advertising and consignment sales 
became standard forms. These marketing features are still 
with us, enhanced by the sight and sound of television.
The term "patent medicine industry" is not used often
today, however, which gives the impression that it is a
long-dead curiosity of the past that we look at as quaint
and humorous. We chuckle at the rubish mentality of those
who suggested that when attending the ill one "ought to
stuff their noses with tobacco, or some other strong
smelling herb" so as to prevent infection, as William Buchan
prescribed in his book Domestic Medicine (1772). Yet the
House Subcommittee on Health and Long-Term Aging, chaired by
Representative Claude Pepper, discovered "cancer cures such
as a compound composed of ground-up diamonds, a tonic made
from warts of horses suspended in sour milk, and serums
7
drawn from human urine and fecal matter." All were 
selling profitably in our modern age of science and logic.
As poet Wallace Stevens so concisely stated, "All history is 
modern history."
6NOTES
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CHAPTER I
THE ORIGINS OF THE PATENT MEDICINE INDUSTRY
In 1687 Thomas Wier, an Edinburgh physician, approached 
King James II and asked for a patent on his invention of 
pills compounded from angelica, a family of herbs.
Anderson's Scots Pills, as they were called, were therefore 
the first patented medicine, one individual being granted by 
law the sole use and benefit of an invention for a limited 
time. The origins of the proprietary medicine industry do 
not necessarily begin here, however. Thomas Wier inherited 
the formula for the medicine from a woman by the name of 
Katherine Anderson. She, in turn, had inherited the formula 
from her father Patrick Anderson, who claimed to be 
physician to Charles I.* Patrick Anderson claimed to have 
learned the formula in Venice, and if this was the case, the 
formula was probably a folk remedy used for generations.
Here lie the origins of the patent medicine industry, in the 
centuries of folklore and folk medicine that preceded the 
seventeenth.
Herbal remedies have been collected for centuries. The 
Chinese seem to have been very proficient in collecting and 
documenting thousands of specimens of materia medica and 
observing their effects on the body. Asthma and bronchitis
7
8were treated by the Chinese 4000 years ago with a juice made 
from a Chinese fir tree. In 1878, it was discovered that 
this herbal remedy was associated with the alkaloid 
ephedrine, which is still vital in treating pulmonary 
disorders.^
Exploration in the fourteenth and fifteenth centuries
made this kind of information available in Europe in a
significant quantity for the first time. European herbal
knowledge was not nearly as complete or thorough as was the
Chinese, and Europe's sciences were steeped in astrology,
witchcraft, and superstition. For instance, W. W. Bauer, in
his book Potions, Remedies, and Old Wives Tales, describes
the use of mistletoe in folk medicine. "The mistletoe, like
other parasitic plants, was greatly revered, perhaps because
of its mysterious ability to grow without roots or other
apparent source of sustenance. It was regarded virtually as
a cure-all, especially for the ’falling sickness 1 (epilepsy),
3because it was 'itself unable to fall to the ground.'"
Folk medicine was, in a sense, an outgrowth of 
desperation. When life hangs precariously in the balance, 
people turn to miracle cures, magic, and religion for help. 
This instinct for survival led to experimentation with 
plants and minerals as medicines, which in turn was the 
basis of modern pharmacy and the patent medicine industry. 
Until the age of exploration, European pharmacological 
knowledge was based more on which plants would harm you 
rather than help you. European knowledge of poisons was
9much more extensive. Most other plant materials they used
a 4 were inert.
Medical historian Howard W. Haggard commented that
"most of the substances that have been used as remedies
depend upon their appeal to the imagination for the healing
5virtues they are believed to possess." Healing powers 
were assigned to many substances just because they were new, 
or very rare, or because they had some kind of unusual 
association. The New World produced a great many plants 
believed to have medicinal properties, not because they were 
rare but because they had never been seen before. Sassafras 
is a good example. It was by no means rare; by 1602 it was 
arriving in England by the boatload from expeditions to 
North America. Sir Walter Raleigh was able to pay for two 
ships to go to America "having saved the charg in 
sarsephraze." At first sassafras brought a price of ten to 
twenty shillings a pound, but the market was soon glutted. 
Raleigh went so far as to have his competitor, Gosnold, 
arrested and his cargo of sassafras impounded so that his 
shipment would make it to market first. Rarity was a 
factor with items such as potable gold, and the gruesome 
associations of mummy dust and Unsea, the mold from a 
criminal's skull, made them sought-after medicinal aids as 
well.
How did these substances, many of which were inert, 
continue to be considered medicinal? As Haggard put it,
"the medicine has an essentially thaumaturgic value; it is a
10
sort of amulet worn internally by which they (the patients)
are periodically nauseated, griped or otherwise forcibly
7
reminded that they are getting well." Any modern 
pharmacological test maintains a control group unknowingly 
given a placebo. In every case, some percentage of the 
control group are or attest to being better. They have 
experienced the same cure as those in the eighteenth century 
who consumed the elaborate placebos of various patent 
medicine vendors. We should never underestimate the power 
of the mind, nor the tenacity of the human body to heal 
itself in spite of the travesties performed on it by nature 
and man. Many patent medicines can therefore attribute much 
of their success to the fact that patients who recovered 
after taking a particular medicine mistakenly established a
g
causal relationship, because one event followed another.
But some herbs and plants did have profound effects on
the body. One class well known in the eighteenth century
were purgatives. The lack of green vegetables in the
English diet made constipation a constant problem.
Medicines with a laxative effect played an important role in
g
almost any treatment. Many, including John Wesley, the 
founder of Methodism and author of a book on home remedies, 
believed that God had intentionally created a plant to cure 
’each ailment. This excited an exhaustive search for materia 
medica, which created the foundation of modern pharmacology 
and the patent medicine industry.
In the late seventeenth century, the patenting of
11
Anderson's Scots Pills started the trend of proprietary 
medicines. By the eighteenth century the growth of the 
industry became explosive both in England and America.
Three factors created the boom: the medical situation at the 
time, a commercial revolution, and the patenting system.
The medical situation in the seventeenth and eighteenth 
centuries was bleak. Medical historian Guy Williams called 
the eighteenth century "The Age of Agony." Williams pointed 
out that the arts of healing developed so slowly at this 
time, because "the social and political conditions that 
prevailed at the time were wholly unfavorable for the 
necessary research." An almost total lack of public and 
personal hygiene, the blithe acceptance of drunkenness, and 
the acceptance of inhumane treatment of fellow humans were 
all contributing social factors.^ William Smith in his 
history of New York (1758) complained of the medical 
situation in the colonies:/
"A few physicians among us are eminent for their 
skill. Quacks abound like locusts in Egypt, and too 
many have been recommended to full practice and pro­
fitable subsistence; this is less to be wondered at, 
as the profession is under no kind of regulation.
Loud as the call is ...we have no law to protect the 
lives of the King's subjects from the malpractice 
of pretenders. Any man at his pleasure, sets up for 
physician, apothecary, and chirrugeon. No candidates 
are eithe r ^ x a m i n e d , licensed, or sworn to fair 
practice."
Inadequate training and regulation was only one 
problem of the medical profession. Medical theories 
abounded, and few were based of scientific study. "The 
colonies," historian Wyndham Blanton observed, "though they
12
had to import their theories second-hand, showed the same 
fondness for speculation in regard to the cause and 
mechanism of disease, and their therapy, founded upon
hypothesis and not fact, was equally fantastic and
12 . . . faulty." Often the prescription of patent medicines was
part of these theories. What we consider quackery today was
often in the eighteenth century considered a valid medical
practise. Robert Turlington, the inventor of Turlington's
Balsam of Life, asserted in his 46-page brochure that the
"Author of Nature" provided "a Remedy for Every Malady"
which "Men of Learning and Genius" have "ransacked" the
13"Animal, Mineral and Vegetable World" to discover."
Many physicians agreed with Turlington and made patent 
medicines an integral part of their practice. A Tudor 
physician, Laurent Joubert, "is said to have complimented 
his mother on her salve, ointment and 'wine of absinthe' 
exactly as he might have praised the recipes used in her 
kitchen."
Further complicating the medical situation, were the
many professions, besides the trained physician, caring for
the ill. There were apothecaries, who since the
establishment of the Royal College of Physicians in 1518,
were considered of inferior distinction, and were subject to
15a physician's oversight. However, since there was a 
scarcity of trained physicians, the apothecary was often the 
only available medical professional with some knowledge, 
having at least served an apprenticeship. In this role, the
13
apothecary not only prepared and sold medicinal compounds, 
but also administered standard treatments of the day, 
including the prescription of patent medicines. The 
apothecary was an important member of the medical community.
Apothecaries and surgeons made up such a large part of 
Virginia's medical community that the colony attempted to 
legislate price-fixing upon their services. The first 
section of the 1736 act well illustrates the problems 
inherent in their practice:
"Whereas the practise of phisic in this colony 
colony, is most commonly taken up and followed, by 
surgeons, apothecaries, or such as have only served 
apprenticeships to those trades, who often prove 
very unskillful in the art of a phisician; and yet do 
demand excessive fees, and exact unreasonable prices 
for the medicines which they administer, and do too 
often, for the sake of making up long and expensive 
bills, load their patients with greater quantities 
thereof, than are necessary or useful, concealing all 
their compositions, as well to prevent the discovery 
of their practice, as of the true value of what they 
administer: which is become a grievance, dangerous 
and intolerable, as well to the poorer sort of people 
as others, and doth require the most e f f e ^ u a l  remedy 
that the nature of the thing will admit."
As the act implies, the use of proprietary medicines of
unknown composition was not uncommon to these apothecaries,
surgeons, and other untrained individuals. At the same time,
a physician's services were expensive, and those who could
not afford it probably bought patent medicines. There were
also many barber-surgeons and midwives filling in the gap of
available, trained physicians. Although these professions
were less educated, they treated a good portion of the
colony's population. One midwife in Williamsburg was lauded
14
at her death by the Virginia Gazette as an "eminent 
midwife" who had "brought upwards of 3,000 children into the 
world. "17
Due to the scarcity of medical professionals in rural
areas, the sales of patent medicines prospered as a
substitute. Medical men were not always available outside
the towns. In 1783, a trader on the frontier of Canada,
shot by a rival, asked for Turlington's to stop the
bleeding. Another man familiar with the discomforts of the
frontier was the Methodist circuit rider Francis Asbury, who
looked to Stoughton's Elixir for an intestinal 
18complaint. When doctors were available, they were
often expensive. Patent medicines, on the other hand, were
reletively inexpensive, and could be stockpiled for any
occasion. The American Balsam of Dr. J. Hill could be
bought at a price of 3/9 a bottle, or by the dozen at 3/3 
19per bottle. Gentleman's Magazine of 1748 prefaced a
listing of patent medicines with this commentary:
"The rich and the great (generally speaking) will 
seek relief from the regular physician, and true-bred 
apothecary; for whom provision is made in the college 
dispensatory. But the majority of mankind (in hopes 
of saving charges, and on a presumption of surer 
help) are apt to resort to the men of experience, as 
they are called, whose remedies they are induced to 
think, from their advertisements (so often repeated, 
and at so great expense) have been successful in the 
cure of several0distempers for which they are 
calculated..."
The rise of patent medicines was also a result of a 
revolution in consumerism in the eighteenth century. More 
people were buying more than ever before in history. Items
15
which had for centuries only been available to the rich
were now available to more of society. Items that before
could only have come to many through inheritance were bought
instead by each generation for themselves. Items that had
been praised for durability were set aside in preference of 
21fashion. In the wake of these changes came the
transformation of marketing; society was commercialized.
Products were produced and marketed with specific economic
groups in mind. "In England," historian Michael Greenburg
states, "commercial capitalism developed as the dominant
mode of production during the seventeenth and early
eighteenth centuries. The growth of foreign and colonial
trade intensified and extended the influence of a money
economy; market forces seeped into all areas of English life 
22and thought." In the area of health, market forces 
seeped in as patent medicines.
Patent medicines were a marketing success. They sold 
well to all classes of society. Patent medicines were not a 
luxury item. Wealthy and poor alike purchased the nostrums. 
Archeological discoveries in Montserratt, West Indies 
discovered a Turlington's Balsam phial in the grave of
individuals believed to be black slaves or indentured
23 . . .servants. Patent medicines were also used m  the
military and the fur trade. Procurement of medicines for 
the military varied through the years, but was generally 
carried out by the surgeon, physician, or apothecary 
attached to the regiment. Archeology found Essence of
16
Peppermint bottles in context in eight frontier military
posts, British and American. Medicines may have been
purchased by individual soldiers from traders, too.
Archeology has revealed the use of patent medicines at sites
of the Hudson Bay Company, the Northwest Company, and the
American Fur Company. It was the fur trade that brought
patent medicines to yet another group, Indians. Indians
probably obtained patent medicines as gifts, as a small part
of the trade, and from traders administering medicine to
Indians. Essence of Peppermint vials were discovered at
24nine different native sites, seven of them in burials.
The rise of patent medicines can be attributed also to
the creation and development of the patent system. The
present system of patenting began in the seventeenth century
as a way of enriching court favorites by granting them
monopolies on an invention or process, on entire industries,
or the development of discovered lands. The lure of royal
revenues, however, seems to have been the stronger motive
for the extensive use of patents by James I, rather than the
25protection of an inventor's rights. His abuse of the 
system brought about conflict with Parliament. In a move 
limiting his power, Parliament passed the Statute of 
Monopolies, which revoked the king's power to establish 
monopolies, except for "the sole working or making of any
O  f i
manner of new manufacture," medicines included.
The American colonies imitated the English patent 
system for granting monopolies for inventions and
17
businesses. They seem to have used them, many times, for
the establishment of a service or product in short supply in
the colony. For instance, Massachusetts granted a monopoly
on salt manufacture in 1646, and in 1750 for the manufacture
27of sperm candles and whale products. No patent seems to
have been issued by any colonial government for a medicine,
2 8though. As Vaughan points out, these patents were
probably effective only on a local level and for a limited
time. Their long-term and general influence was slight.
"Their common use, in New England especially, to encourage
new industries appears to have been due to an acquired habit
29of legislation rather than for successful experience."
This colonial system was continued by the Articles of
Confederation, with about as much success. Under the
Constitution, the first United States patent law was enacted
on April 10, 1790. The system was strict and unpopular,
however, and a new law was passed in 1793. The 1793 act was
the only U.S. patent law that did not provide for any
examination into a candidate's novelty or utility? that was
30to be decided m  the courts. So, unfortunately, we know 
only the names of the applicants and their medicines under 
this law; no formulae survive.
Patent systems were intended to promote inventiveness 
among the population by rewarding the efforts of the 
inventor. The reward-by-monopoly thesis, as historian H. I. 
Dutton points out, "was based on the notion that inventors 
should be rewarded according to the usefulness of their
18
invention. Since reward cannot be guaranteed by ordinary
market forces, the state should intervene to provide a
31temporary monopoly." The effectiveness of this system
in promoting inventiveness has been debated since the
creation of patenting. In 1774, W. Kendrick wrote An
Address to the Artists and Manufacturers of Great Britain
where he argued that the "most plausible and politic method
of bestowing that encouragement is therefore, that by which
the eventual utility of such invention is made the measure
32of reward. This is effected by letter patent. However,
in 1836 a letter in Mechanics Magazine in England complained
of the "misfortune, and not a small one, that patents for
inventions have descended historically as arbitrary grants
of privilege... and this erroneous view...has not been
33entirely discarded to this day."
What was the system's effect on patent medicines? Was 
it an incentive to their development? At first it would 
seem not. The title "patent" medicine is misleading, for 
many of these medicines were actually never patented. Most 
would be considered proprietary medicines, but the term has 
come to include all of them. It also seems that the system 
created as much counterfeiting as inventiveness. Neither in 
England nor America could many be restrained from profiting 
illegally from the pirated name of an established medicine. 
The London Advertiser of October 29, 1743 carried in the
same column almost identical advertisements for "Daffy's 
Elixir" and "Dr. Daffy's Elixir." Each claimed to be the
19
genuine article. Each claimed its trademark was the
34original, and each warned of counterfeiters.
In spite of the non-patented medicines and the amount 
of counterfeiting, the patent system did provide some 
incentive to inventors. While many medicines were not 
patented, many others were. Some of the earliest patents 
approved in England and America were for medicines, such as 
Lee's Bilious Pills patented in 1796 as the first medicine 
under the fledgling U. S. Patent Office. During that
office's first 46 years, seventy-five patents were granted
. . 35covering a variety of medicines.
While fighting counterfeiting was a difficult
proposition at any time, it was almost impossible in a
court of law without a patent. Joseph Cruttenden, a London
merchant, was stocking and selling Stoughton's Elixir in 
3 61711. A patent for Stoughton's was not taken out until
1712. The patent was probably an attempt to curtail 
counterfeiting of a medicine that had already been on the 
market for some time. So the patent system did have an 
effect on the growth of the industry. It was a significant 
part of the origins of the explosive growth of these 
medicines in the eighteenth and nineteenth centuries.
With its origins in centuries of folk medicine, the 
patent medicine industry established itself in the late 
seventeenth century. While it started from humble 
beginnings, the industry, encouraged by the inadequacies of 
medicine, better marketing, and patent systems, developed at
20
a very rapid rate in the eighteenth century. By 1748, The
Gentleman * s Magazine printed a partial list of proprietary
37medicines m  England which had 202 entries. Many were 
exported to the American colonies.
21
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CHAPTER TOO 
THE DEVELOPMENT OF THE AMERICAN MARKET
The patent medicine business was in its infancy when in 
the early 1600s the first successful English voyages were 
returning from North America. These voyages, as well as 
those to Africa and the Orient, helped spur the industry's 
growth by returning with cargoes of new herbs and plant 
materials to excite the investigations of physicians and 
apothecaries throughout England. The early voyages returned 
with great quantities of sassafras, ginseng, tobacco, and 
other roots and barks believed to be of medicinal value. A 
description of the resources of the lands around Jamestown 
written probably by Gabriel Archer in 1607, noted many 
"Apothecary drugges of diverse sortes, some known to be of 
good estimation, some strange of whose vertue the salvages 
report wonders.
The search for medicinal plants encompassed the entire 
eastern seaboard. Apothecaries were interested in the 
medicinal possibilities of American plants, while merchants 
were interested in the economic possibilities. The search 
continued through the eighteenth century. Jefferson was one 
of many who promoted the search in Virginia. In his Notes 
On Virginia, he listed twenty-one medicinal plants native to
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the region. Of those, at least eight were being exported 
in significant quantities by the middle of the eighteenth 
century.^
In the eighteenth century, materia medica was exported
consistently, but in limited quantities. Medicinal plants
continued to be exported to England until the Revolution.
The war years interrupted the trade, but like most items it
resumed after the hostilities ceased. In 1790, the
exportation of medicinal drugs from the United States
amounted to $1,735. The very next year, the value of drug
exports more than doubled to $4,233, and by the end of the
century the exports of raw drugs in 1800 amounted to 
3
$23,477. Throughout the eighteenth century the country 
continued to export materia medica, but America's importance 
to the patent medicine business lay more in its consumption 
of the finished products of England's apothecaries, 
physicians, and businessmen.
The same materials the Americans exported were, under 
the colonial trade system, reimported in the form of patent 
medicines. In 1770, The Pennsylvania Gazette ran an 
unusually large advertisement for an English patent medicine 
called the American Balsam. According to the inventor, a 
London physician by the name of Hill, it was entirely 
"prepared from some new American plants, sent to England by 
that ingenious gentleman Mr. William Young, of Pennsylvania, 
Botanist to their Majesties the King and Queen of Great 
Britain." Dr. Hill's medicine was an accurate reflection of
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the lack of American industry created by the British
mercantile system. In this case, the raw materials and the
market were both in North America, yet the manufacture of
the product was in England. Despite the foreign production,
the marketing of Dr. Hill's balsam was directed specifically
to the American market. "As this medicine is prepared from
the American plants," he instructed, "no wonder it must have
the best effect in that country; as it is most natural to
4the constitution of the people."
The American Balsam of Dr. Hill was a latecomer to the.
American market. Patent medicines were sold in the colonies
at a much earlier date. When the first patent medicines
arrived in America is difficult to say. Of the first 225
men sent to Jamestown in 1607 seven were practitioners of
medicine. It seems likely that one of them would have taken
a package of Anderson's Scots Pills or one of the other
early English patent medicines, although no mention is
specifically made of one. According to one document, one of
these men, George Liste, was sent "with a Chest of
Ch[i]rurgery sufficiently furnished," which may have
contained some patent medicines. Even if this first voyage
was not supplied with patent medicines, later voyages likely
were, since Liste was allowed to return to England "the
better to enfourme us [the London company] what medicines
and drugges are fittest to be provided for the use of the 
5colonie." Unfortunately, we do not know what Liste's 
recommendations were, or if he even ever made it back to 
England.
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The hardships of sea travel and the thought of settling 
in a "untamed wilderness" cut off from the culture of native 
England were sobering thoughts. Sickness and death were 
ever-present consequences, and patent medicines would have 
provided some hope for relief for these early settlers. One 
of the earliest references to the use of a patent medicine 
in New England appears in 1630. In that year, a gentleman 
by the name of Nicholas Knopp of Massachusetts Bay was 
punished "for taking upon him to cure the scurvey by a water 
of noe worth nor value, which he solde att a very deare 
rate. "6
These early clues hint at the presence of English
patent medicines, but the earliest reference of an actual
medicine is found in a Surry County, Virginia inventory.
The inventory of George Proctor, recorded in 1678, lists "18
7boxes of Lockyer1s Pills." In 1684 William Byrd I 
requested merchants Perry and Lane of England to send along 
with his window glass, sodder, and lead "10 boxes of
g
Lockyer1s Pills." These late-seventeenth-century 
examples were just the beginning of the American market for 
patent medicines. There is a distinct lack of patent 
medicine advertisements in newspapers in the early 
eighteenth century. While this may suggest that the use of 
patent medicines in America at this time was infrequent, it 
is also probably the result of limited and therefore 
expensive advertisement space. By 1750, though, the use and 
advertisement of patent medicines was prevalent.
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While it was small at first, the American market was 
not a secondary market or a bonus to English patent medicine 
merchants. It was a vital part of the English merchants' 
marketing strategy, a vital part of their profits.
Otherwise, patent medicine vendors such as Robert Turlington 
would not have personally entered a newspaper feud of 1760 
and 1761 in the New York Mercury. His Balsam of Life was 
being sold by five different individuals, each arguing over 
their right to vend Turlington's medicine or what they said 
was Turlington's. Colonial consumers were in such a 
quandary, that Turlington, keeping abreast of American 
developments, stepped into the feud to resolve it. He 
warned against counterfeiters and denied the allegation of 
one man who claimed an exclusive franchise of the medicine. 
Furthermore, Turlington sent a supply of his medicine to the
editor of the Mercury in order to provide consumers with a
. . . 9legitimate source for the authentic balsam. Turlington's
problems with distribution and counterfeiting were typical 
of patent medicine vendors throughout the colonies. The 
difficulties Turlington encountered in America, though, were 
not new or unique. Shrewd American merchants had adopted 
the vices and marketing techniques of the English merchants.
The marketing techniques developed by merchants in the 
eighteenth century were the basis for the patent medicine 
industry in the nineteenth and twentieth centuries, modified 
only slightly by technology such as mail-order services, 
radio, and television. The most important difference was
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the change in location of the manufacture of patent 
medicines. Throughout most of the eighteenth century, the 
manufacture of patent medicines had been, almost without 
exception, based in England. In the late eighteenth and 
early nineteenth centuries, Americans began to manufacture 
patent medicines in large quantities.
Until the Revolution, patent medicines in America were 
almost always imported. Most came from London. Many of 
the New England merchants had their origins in this city, 
and once in the colonies, they established their trade 
connections with those whom they had known and left behind 
in England. Therefore, not only medicines but most goods 
sent to America arrived from warehouses in the center of 
L o n d o n . ^  At these warehouses, firms such as Robert 
Turlington's, Francis Newbery, and Okell & Dicey, made and 
sold their medicines, while stockpiling other patent 
medicines to be exported to the colonies. The firm of Okell 
and Dicey had created the very popular medicine Bateman's 
Pectoral Drops (patented in 1726), which they made and sold 
at their warehouse at Bow Churchyard, Cheapside, London.
Many other brands of patent medicines also passed through 
their warehouse on their way to American merchants.'*'1
The inventor of a patent medicine could also be the 
manufacturer, such as Robert Turlington and Richard 
Stoughton, an apothecary in Southwark, Surrey, who produced 
Stoughton's Elixir. More often merchants claimed to have 
received the "original" formula from a "more learned"
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source. This claim/ they felt, gave their patent medicine
more legitamacy. Daffy's Elixir was one of the most popular
patent medicines of the eighteenth century. It was said to
have been discovered by a Reverend Thomas Daffy around 1750.
The medicine was never patented, though, and after his death
the medicine was manufactured by many different companies
often with a slightly different version of the name and a
great diversity in formulas. Likewise, Richard Stoughton's
death in 1726 created a frenzy of copies, and feuds ensued
12as to the owner of the original formula.
Some producers licensed merchants to sell their 
products, often, though unsuccessfully, in an attempt to 
discourage counterfeiters. No matter who manufactured the 
medicine, its sale to the colonies was usually on a 
consignment basis. Patent medicines were often sold to 
distributors in the colonies. These merchants and 
apothecaries might sell some of the medicines individually, 
but often they were more interested in selling the lot to 
other merchants rather than dealing directly with the public 
themselves. Dr. Hill of London instructed William Young, 
his authorized merchant in Philadelphia, to accept 
Pennsylvania currency so "that the shop-keepers, and others, 
in Philadelphia, who buy to sell again, might have about a 
Shilling profit on each bottle; and masters of vessels, 
shop-keepers, and others who live far in the country, or 
other provinces, who may have greater expenses, may there 
sell said balsam, for the price mentioned in the bills, for
13the value in sterling money." These instructions were 
included in the advertising to encourage others to buy in 
gross for resale.
Marketing patent medicines in this manner allowed the
public to purchase them from a wide variety of individuals.
They were not sold exclusively by apothecaries and
merchants. Once acquired for resale, patent medicines could
be purchased from the post office, tavern keepers, and
various craftsmen. Almost everyone sold patent medicines at
one time or another, since they were not difficult to buy or
store, and the market for nostrums was good enough to make a
quick profit. Ship's captains seem to have often been
involved in the sale of patent medicines. For them patent
medicines represented a product that took minimal room to
transport, and yet sold well in the many ports they might
visit bringing a tidy sum. Even the tailor Robert Hutchings
14m  Petersburg, Virginia sold patent medicines.
Although many were quack remedies, many other patent 
medicines were considered valid. Their use was accepted as 
part of the medical theories of the time, and many doctors 
were not averse to selling patent medicines. Dr. George 
Gilmer of Williamsburg was the first to advertise the sale 
of Anderson's and Bateman's Pills in 1737.15 He had 
studied medicine at the University of Edinburgh, and 
practiced in London before he came to Virginia in the employ 
of a land company. After spending a brief time in Virginia, 
he returned to England to marry the daughter of the doctor
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under whom he had practiced. He returned to Virginia after
1 fi
her death in 1731. This time he settled in Williamsburg 
to practice medicine, which included the sale of patent 
medicines. He probably prescribed the medicines to those 
under his care, but also, for extra profit, sold them to 
those in need of medical care but unable or unwilling to pay 
for his services.
This proliferation of vendors is one of the factors
that made counterfeiting a rampant practice in the marketing
of patent medicines. If imitation is the sincerest form of
flattery, many of the original inventors and producers of
patent medicines were frequently flattered. The lack of
government regulation and inspection, and less concern than
today on the part of the public, made counterfeiting a
simple and prosperous activity. Most victims seem to have
been able to do little more than warn their customers to be
wary of imitations and hope that they took heed. To impress
upon consumers the worst of consequences seems to have been
considered the most effective tool. "I do advise all
persons, for their own safety," warned a Hertfordshire
vendor in 1721, "not to meddle with the said Cordial
[Godfrey's Cordial] prepared by illiterate and ignorant
Persons, as Bakers, Malsters, and Goldsmiths, that shall
pretend to make it (Godfrey's Cordial), it being beyond
their reach; so that by their Covetousness and Pretensions,
many Men, Women, and especially Infants, may fall as
17Victims, whose Slain may exceed Herod's Cruelty..."
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Another factor built into the marketing of patent
medicines that encouraged counterfeiting was the consistent
packaging of nostrums. Consistent bottle shape and labeling
made patent medicines easily recognizable even to the
illiterate. In this way manufacturers insured that
consumers could always find their product even though it was
not sold by the same person or at the same place.
Consistent packaging therefore encouraged repeat customers,
but it also encouraged counterfeiting. As Griffenhagen
points out, the proprietor might be able to retain his
secret formula, but the reproduction of the bottle or its
18wrapper was relatively simple. The London merchant
Joseph Cruttenden faced this problem and admitted to a
Salem, Massachusetts customer that, "I cannot positively
assert the Tincture to bee the same with Stoughtons, but it
is very near it and I believe it as good; I gott all the
light I could possible into his medicine and I dare affirme
this will performe whatever his will; you may give them the
19same directions about taking them."
Such a lack of concern for authenticity as Cruttenden's 
forced most manufacturers to accept counterfeiting as 
legitimate competition. However, one proprietor who 
attempted to thwart his unethical rivals was Robert 
Turlington. Turlington patented his Balsam of Life in 1744.
It became one of the best selling nostrums in England and 
the colonies, but it also became one of the most 
counterfeited. In an attempt to curb the copying,
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Turlington changed the shape of his bottle three times. His
first bottle was square and impressed with a coat of arms.
By 1749/ though, Turlington complained that the Whitefriars
glasshouse was manufacturing his vial and selling it to
competitors. In response, Turlington changed the vial to a
chello-shaped bottle. Again competitors caught up with him,
and in 1754 he altered the bottle's appearance to a
20pear-shape with an elaborate inscription.
The shape of the bottle, more than the inscriptions
seems to have been considered the important element to
accurately copy. A Turlington's bottle found at Montserat,
West Indies compared almost exactly in shape to a
Turlington's bottle found in archaeological excavations in
Williamsburg, Virginia. The most striking difference,
though, was the patent date. The Montserrat bottle was
dated October 29, 1751, whereas the Williamsburg vial was
dated March 25 or 26, 1750. A comparison with other bottles
suggested that the Montseratt vial was one of the many
21counterfeits that plagued Turlington.
The shape of the vial was important to maintain because 1
/
it affected not only product recognition but also the 
dispensing of the medicine. Most patent medicines in liquid 
form in the eighteenth century were prescribed by drops.^
Most prescribed a certain number of drops to be added to 
another drink, usually alcohol, tea, or water. The 
manufacturer of Stoughton's Elixir recommended a dose of 50 
to 60 drops of the Elixir "in a glass of Spring Water, Beer,
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Ale, Mum, Canary, White wine; with or without sugar, and a
22dram of brandy as often as you please." Variations m
the angle of the shoulder and neck, the shape of the body,
and the shape of the finish all affected the size of the
drop and consequently the amount taken, which was especially
important for medicines that contained dangerous substances
23such as laudanum.
Counterfeiting and the practice of sale for resale 
prove that there was a substantial and competitive market 
for patent medicines. In this competitive market, 
advertising became the essential tool for success. The 
eighteenth-century merchant turned primarily to newspapers 
and broadsides. The periodical originated from a need to 
inform buyers of the goods available from various merchants. 
The first periodical, the French Journal of Public Notices, 
seems to have been a want-ad format. This format was copied 
in England as The Publique Register for generall commerce.
It provided a medium where buyers and sellers could list
their goods or needs to be distributed across the
24 .country. These early listings developed into the paid
advertisements that revolutionized marketing. With
newspaper advertising merchants could, relatively
inexpensively, inform buyers over a large area of their
stock, and with a few more sentences convince the uncertain
consumers of their need. Patent medicine vendors were some
of the earliest to take advantage of this medium.
The earliest newspaper medicine advertisement seems to
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be in the English publication News(1664). "SMALL BAGGS,"
began the pitch, "to hang about Children's necks, which are
excellent both for the prevention and cure of the Rickets,
and to ease Children in breeding of Teeth, are prepared by
Mr. Edmund Buckworth, and constantly to be had at Mr. Philip
Clark's, Keeper of the Library in the Fleet, and nowhere
25else, at 5 shillings a bagge." The first American
patent medicine advertisement appeared in the Boston
News-Letter on October 4, 1708. Nicholas Boone at the sign
of the Bible advertised: "Daffy's Elixir Salutis, very good,
at four shillings and sixpence per half pint bottle."
English advertising techniques developed quickly in t h e ^
eighteenth century. The patent medicine ads became essays
complete with lengthy descriptions of the medicine's
properties, numerous testimonials to its success, and
elaborate, even outrageous, stunts to draw the attention and
business of the curious public. A Mr. Van Butchell in
England in the 1770s went so far as to advertise the showing
of his deceased wife's embalmed body to draw potential
27patients to his practice.
Across the ocean American newspaper advertisements 
resembled more the early registers of the first English 
periodicals. With a few exceptions, the vast majority of 
advertisements were merely a list of goods "just arrived." 
"Just IMPORTED in the Rachael, Capt. Armstrong;" announced 
the Virginia Gazette in 1751, "and to be SOLD reasonably, by 
the Subscriber, in Williamsburg, A Choice Assortment of
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Drugs and Medicines consisting of Jesuits Bark, Ipecacuana,
Sarsparilla and China Roots... Anderson's, Lockyers Pills,
Bateman's Drops, Squires, Daffy's and Stoughton's 
2 8Elixirs..." Most American ads followed this exact 
format of simply listing the medicines and did not 
elaborate. The shortage of advertising space in the few 
colonial newspapers made further elaboration expensive. An 
extensive description of the medicines was also probably 
unnecessary to sell the product, since there was already an 
inadequate supply to meet the demand. Little more than 
announcing their arrival was needed to deplete the seller's 
supply.
Newspapers were not the only printed material to offer 
opportunity to the patent medicine vendor. Pamphlets and 
broadsides were an important part of the marketing of patent 
medicines. These could range in size from one page to small 
books of 40 and 50 pages, such as those of Robert 
Turlington. This medium offered the manufacturers the 
opportunity and space to elaborate and detail the qualities 
of their goods, something the newspapers could not do. Some 
pamphlets even contained illustrations such as one showing 
"the kneeling patent medicine man presenting George III with 
a packet, and with this caption:
His Majesty on the Esplanade at Weymouth 
graciously accepting a Box of Ching's Patent
Worm Lozenges which was presented to him
. . 29as a Patent Medicine."
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Broadsides were often used as the label for bottles. 
They contained testimonials to the powerful effects of the 
medicine and instructions for the medicine's use. A critic 
of physicians in New York in the 1750s complained that 
physicians relied on patent remedies that they read about in
"London Quack Bills." These bills were often, he protested,
. . . 30many physicians' only reading material. Dr. William
Douglass, commenting on the American colonies, noted "How
dismal is it to observe some apothecarie's shops wainscotted
or papered with advertisements, recommending quack medicines
for the profit of the shop, but the destruction of their 
31neighbors."
Most of these broadsides and pamphlets were printed in
England and imported, although some were printed in the
colonies. The first medical pamphlet published in New York
in 1731 was An Abstract of the Patent Granted by his Majesty
King George to Beni. Okell, the Inventor of a Medicine
32call'd D r . Bateman's Pectoral Drops. The eighteenth
century was an age of pamphlets and essays written on almost
every subject. Those dealing with medicines and medical
theory were read as avidly as those on political subjects.
One of the earliest in America to deal with home medical
treatment was Every Man his own Doctor: or the Poor Planters
Physician. Printed in 171)34 and sold by William Parks at his
printing offices in Williamsburg and Annapolis, the pamphlet
33even contained formulas for remedies.
While most vendors used advertising to draw customers
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to their business, the peddler took his nostrums to 
potential customers. The few references to peddlers of 
patent medicines seem to uphold the image of the peddler as 
a mountebank with something to hide and always encouraged to 
move on. "On Thursday last," the Pennsylvania Gazette 
reported, "a Person that went by the name of Charles 
Hamilton, came here, and offered to Sale at several Houses 
in Town Sundry Medicines for different Disorders; pretending 
he was brought up to the Business of a Doctor and Surgeon, 
under one Dr. Green." Upon closer inspection, suspicious
townspeople discovered the peddler to be a woman and she was
• j 34 j ailed.
In an earlier event, a travelling peddler by the name
of Torres arrived in Philadelphia and took an ad in the
Pennsylvania Gazette promoting his "Chinese stones." "Mr.
Torres will in a short Time set out for New-England; Those
that are inclined to buy his Powders, may find him at Mr.
Jacob Duche's , in Market Street, or at Mr. Anthony Duche1s ,
the Dyer." Before Mr. Torres could leave for New England,
however, another ad appeared revealing his "stones" as
nothing more than blackened buckshorn wood. "Your Sawdust,
and Raspings and chips of the same Horn, burnt in the same
Manner, and put into a little Linen Rag makes the miraculous
35Chymical or Comical Powder." Mr. Torres may have left 
Philadelphia in a hurry.
No matter how patent medicines were sold in America 
throughout the greater part of the eighteenth century, the
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^  vast majority were English imports. As in so many other 
industries, the English mercantile system produced a product 
cheaper and better than the colonists could make it 
themselves. Along with strict regulations, the colonial 
system dampened American enterprise. It took a cataclysmic 
event and many years afterward to shake the yoke of English 
industrial domination. The Revolution made many aware of 
their acute dependence on the British for medicines, and at 
the same time they realized the potential of their own vast 
resources which could replace the British nostrums. Dr. 
Johann David Schoepf, traveling in the states in 1783 and 
1784, commented on this dilemma:
"It is to be wished that the physicians in 
America, who have already in other matters, shown 
their patriotism in many noble efforts, may also 
have a patriotic eye to the completer knowledge 
and more general use of their native materia 
medica. It betrays an unpardonable indifference 
to their fatherland to see them making use almost 
wholly of foreign medicines, with which in large 
measure they might easily dispense, if they were 
willing to give their attention to home products, 
informing themselves more exactly of the properties 
and uses of the stock of domestic medicines already 
known... and they would be working usefully for the 
poor if they made it their business to further the 
employment of the manifold wealth affo^ged by 
nature in its precious gifts to them."
As the eighteenth century drew to a close, society in the
last decades witnessed American entrepreneurs take up
Schoepf's challenge. The production and sales of American
patent medicines soon eclipsed British imports.
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CHAPTER THREE 
THE DEVELOPMENT OF THE AMERICAN INDUSTRY
While imports dominated the American patent medicine 
market, examples of American entrepreneurship did exist, 
primarily in the form of counterfeiting. James Carter of 
Williamsburg made and sold his own version of Stoughton's 
vials. ^  He apparently produced the medicine and packaged 
it in counterfeit bottles imported from England. The 
formula might have been one of his own creation, or he may 
have used a formula published under Stoughton's name. 
Formulas for popular proprietary medicines were published in 
various pharmacopoeias and books on domestic medicine.(see 
Appendix A)
Another Williamsburg doctor produced his own patent
medicines and bottled them in imported counterfeit vials.
Dr. William Pasteur in 1768 ordered one half gross of "botts
for Daffy's Elixir empty," along with "Quincey's
Dispensatory last Editn," which contained the formula for
2
Daffy's and Stoughton's Elixir. Similar practices 
probably occurred throughout the colonies, and men like 
Carter and Pasteur represent the first inkling of an 
American patent medicine industry. However, their efforts 
constituted only a small proportion of the patent medicine 
business. The colonies were dependent upon England for 
imports of proprietary medicines. That dependence would 
become critical as the Revolution loomed ever closer.
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Colonists were made frighteningly aware of their 
dependence early in the confrontations before the war. Drugs 
and medicines were not included in the fury of 
nonimportation in response to the Townsend Acts. The 
resolution on nonimportation of the Virginia House of
Burgesses on June 22, 1770 did not include drugs or
3medicines m  the list of items to be boycotted. The 
merchants of Boston specifically listed drugs and medicines 
along with tin plates, die stuffs, and school books as items
4
exempt from their agreements of nonimportation. Patent 
medicines were too important to the daily lives of the 
colonists to risk losing them, even as a political 
statement.
In the years before the outbreak of the war, as
nonimportation again became an issue, a Maryland merchant,
John Boyd, used the threat of patent medicine's inclusion in
the nonimportation resolutions to boost his business. He
advertised in the Maryland Gazette of September 29, 1774
that he had just received a fresh supply of medicines, and
with nonimportation being considered again, he advised his
customers to purchase the medicines immediately before
5supplies ran out. What John Boyd did not know was that 
it was not the nonimportation acts which would cut off his 
supplies but the war.
The outbreak of the Revolutionary War began a process 
of significant change in the patent medicine business. It 
marked the decline of the importance of English patent
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medicines in America. The war created a crisis in the
business. Added to the regular demand of patent medicines
were the massive needs of the military. The British moved
quickly to ensure that these needs were not met. The
British blockade effectively cut off the shipments from
England that had been arriving regularly since the 1730s,
and the army moved to capture existing supplies. As General
William Howe moved into Boston, he realized the importance
of the medicinal stores, and by his order "all the drugs and
medicines in the town [were] seized for the use of the 
6army."
Some of these pre-war stores seemed to have lasted well 
into the war years. The Williamsburg apothecary W. Carter 
in an inventory of 1779 still had patent medicines,
7including the remedies of Anderson, Bateman, and Daffy. 
However, this was unusual, and as the armies moved toward 
Virginia, Carter's supply was undoubtedly used quickly. 
Shortages were often the result of inefficient transport 
and communication on the part of the military, rather than 
inadequate supply. In August 1776, medical supply officers 
begged the Congress in Philadelphia for drugs. At the same 
time, John Thomson of Petersburg, Virginia was advertising a
g
wide assortment of medicines and other medical supplies.
To meet the demand for drugs and medicines, Americans 
turned to several sources. While the British blockade was 
effective, it was not perfect. Medicines were successfully 
imported from other countries in Europe and the West Indies.
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The British, attempting to halt the intercoastal trade as 
well, were much less successful, and drugs and medicines 
moved from colony to colony. A Salem, Massachusetts / 
merchant shipping medicines in 1777 made sure to take 
precautions against British discovery. In his account book, 
the following entry appeared: "The above 13 packages and 4
cases of medicines are ship'd on Board the Sloop Called the 
Two Brothers Saul West Master...The cases are unmarked being 
ship'd at Night."^
The smuggling of medicines was a dangerous undertaking 
and provided an inconsistent supply, and thus other sources 
were needed. Pirating, therefore, became a lucrative 
business that supplied medicines to the Continental Army.
Many British ships met a fate similar to the Richmond, which 
was captured by the Americans in August 1776. She had left 
London bound for Halifax and among the booty of gold and 
sugar were "3 cases of d r u g s . O v e r  a thousand vessels 
were captured by Massachusetts privateers alone, and drugs u.—  
and medicines destined for the British army were often part 
of the cargoes. One privateer recorded in his ledger the 
payment of 62 pounds from the Massachusetts government for 
drugs taken from the captured ship Julius Ceasar, and 
another payment of 170 pounds for the "drugges taken in the 
prize Brig Three Friends.
Another option available to the Americans was to use 
their own resources and knowledge to produce the medicines.^ 
Wars throughout time, while bringing death and d e s t r u c t i o n , ^
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have also always brought the chance for some people to 
profit. The American Revolution was no exception.
Therefore, the most important result of the war for the 
patent medicine industry was the American substitutes that ^  
were produced. These remedies, created as a necessity of 
war, became the steady-selling post-war American patent 
medicines that would overtake their British counterparts in 
a decade.
After the war, when peace resumed, British goods 
quickly returned to the American market. This flood of 
English manufactures included patent medicines. However, 
the merchants of the old English patent medicines did not 
find the lucrative markets of pre-war America awaiting them. 
Instead, throughout the states, British merchants competed 
with many small American drug and medicine firms that had 
sprung up in the war years and immediately after. By the 
turn of the century, many of those small concerns had 
developed into larger interstate businesses. An 1804 drug 
catalogue of Jacob Scheiffelin of New York still listed the 
old English medicines of Anderson's, Godfrey's and 
Turlington's. However, the English medicines were far 
outnumbered by new American products by manufacturers such
Henshaw's of Boston listed even fewer English medicines. By 
this time the old English patent medicines had all but 
disappeared from the American scene.
Although American firms continued to sell the old
as Lee, Perrin, or Ryan. 12 The list of John
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English patent medicines, they also produced American 
versions of the best-selling English medicines. Therefore, 
most warehouses were selling two versions of English patent 
medicines, one English or "true" and one American or 
"common" as they were listed in the catalogues. John 
Henshaw's catalogue of 1834 sold three versions of the 
venerable Anderson's Pills. One was a generic English 
brand, one an American brand, and one, he noted, was 
specifically from the English firm of Dicey and Company,
which was one of the oldest English firms selling patent
... 13medicines.
The lack of concern for patents and ownership of patent
medicines that had been so aptly demonstrated in the
counterfeiting of the eighteenth century carried on into the
nineteenth. Copying of medicines was rampant In 1837 the
free use of old English medicine names received officials"
sanction from a Massachusetts court which ruled that the old
English patent medicine names had "acquired a generic
meaning descriptive of a class of medicines, names which
14everyone was free to use and no one could monopolize." 
English merchants could not compete with this kind of 
competition. American versions could almost always be sold 
at considerably less than the imported medicines, and in a 
market where name and origin meant very little to the 
consumer, price meant everything. Henshaw's of Boston sold
the English version of Anderson's Pills at $15.00 a gross,
15whereas the American version sold for $5.00 a gross. An
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apothecary in Salem, Massachusetts offered Turlington's
Balsam from London at 36 shillings a dozen, while his "own"
1 6was a mere 15 shillings.
English medicines had to compete with the lower
manufacturing costs of American domestic medicines and the
country's tariffs. As a direct result of the devastating
costs of the Revolution, the British government further
crippled British patent medicine exports by taxing them. In
1783, the first British patent medicine tax was passed. The
products went tax-free only if they disclosed their formula,
17an action the government was certain few would do. A
similar tax was not imposed on American patent medicines
until 1862. Ironically, this act too stemmed from the need
to finance a war. To field an army to defeat the southern
insurrection, Congress passed a comprehensive excise tax
bill that included stamp duties on proprietary 
18medicines. Until this time, however, British patent
medicines had to compete with untaxed American brands.
Not even the British government stamps could ward off
American copies that sold for much less. Americans merely
copied the stamp as well. "Many, very many days,"
recollected a Boston druggist of his apprenticeship in the
1820s, "were spent in compounding these imitations, cleaning
vials, filling, corking, labelling, stamping with facsimiles
of the English Government stamp, and in wrapping them
with...little regard to the originator's rights or that of
19their heirs ..."
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To further increase the competition, American patent 
medicine vendors picked up the bold advertising and 
marketing techniques of their English counterparts, which 
they had lacked in the eighteenth century. Americans became 
more creative in naming their products. Whereas the few 
colonial American products had simple, explanatory names 
such as "Ointment for Itch," the new American product names 
were livelier, such as Bilious Cordial, Cordial Restorative 
Balsam, and the Infallible German Corn Plaister. As the 
names became bolder, so did their printed claims. Samuel 
Chamberlain of Massachusetts patented his Bilious Cordial on 
December 31, 1804. In an 1807 pamphlet describing the 
medicine, Chamberlain asserted that "this Cordial has cured
every one who has taken it for the piles, that has come
within my knowledge many who have been afflicted with it a 
number of years." In his pamphlet, Chamberlain also 
included many testimonial of those who had used or 
administered the wonderful Bilious Cordial:
"One man to whom I administered my Bilious
Cordial, told me had been in a habit of puking once a
every twenty four hours for 3 years or more, so 
costive as not to be uncommon to pass from one to 
three weeks without a natural evacuation. In the 
rage of his disorders, he commenced taking the 
Cordial— he got down nearly a bottle before it had 
much effect; but in about week, without taking more 
than two bottles, his whole system appeared to be in 
perfect regulation. I have lately been informed of a 
similar complaint, being cured by the cordial in a 
woman who had been in the habiijgOf puking up her 
breakfast for thirteen years."
Many of the marketing practices established by the 
British were continued and expanded in the United States.
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The practice of selling primarily wholesale continued in 
America, and their marketing reached further than their 
local area. In 1799 "Dr. Church's Genuine Medicines," were 
"sold wholesale by the INVENTOR and sole PROPRIETOR, Dr.
James Church, at his Dispensary, upper end of Broadway, and 
Office, No. 10, Courtland Street, New-York." He also listed 
his appointed representatives (doctors, booksellers ,  i m ­
printers, and postmasters) in New York, New Jersey,
Massachusetts, Delaware, Pennsylvania, Virginia, and even
21St. Johns, Nova Scotia.
Peddlers continued to criss-cross the states selling
patent medicines, and apparently their reputation had not
changed much from that of the eighteenth century. Nathaniel
Hawthorne recorded his impressions of a peddler he met in
1837. "A vendor of patent medicines, Doctor Jaynes, makes
acquaintance with me, and shows me his recommendatory
letters, in favor of himself and drugs, signed by a long
list of people. He prefers he says, booksellers to
druggists as his agents, and inquires of me about those in
this town. He seems to be an honest man enough, with an
intelligent face, and sensible in his talk--but not a
gentleman, wearing a somewhat shabby brown coat and mixed
pantaloons, being ill shaven, and apparently not well
22acquainted with the customs of a fashionable hotel."
The man Hawthorn met, Dr. David Jayne, was a travelling 
doctor, who dispensed cures from his saddlebags. He had 
studied at the University of Pennsylvania from 1818 to 1822.
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His practice in Salem, New Jersey had led him to the
conclusion that time was vital in prescribing medicine to
relieve pain. In response, the doctor developed Dr. Jaynes
Family Medicines in 1830, which could be prescribed when a
doctor was not available. This was the beginning of a
23family business that exists today in Philadelphia.
After the war American entrepreneurs quickly caught up
with, and soon crippled, the British imports of patent
medicines. They were so successful that the editor of the
New York Advertiser reflected that "Perhaps no past period
in the history of this country has teamed with such a
multitude of medical mountebanks as the present. The
vendors of patent medicines in almost every capital town in
the United States are fattening on the weakness and folly of
24a deluded public."
The first of these patent medicine vendors to actually 
secure a patent from the United States government was Samuel 
Lee, Jr. of Wyndham, Connecticut. In 1796 Samuel Lee 
secured a patent for his Bilious Pills Advertised to cure 
yellow fever, jaundice, dysentery, dropsy, and worms; as the 
first American medical patentee, Lee appropriately labeled 
the medicine with an American eagle. In the tradition of 
patent medicines, Lee's success was followed by copies. In 
1799 another patent was granted for Lee's Bilious Pills, 
only these were the product of a New London, Connecticut 
physician by the name of Samuel H. P. Lee. Apparently the 
second Lee decided to profit from the coincidence in similar
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name and residence, and developed his own version of bilious 
pill. Samuel Lee, Jr. warned the public, "If people 
incautiously purchase his [Samuel H. P. Lee] Pills for mine, 
I shall not be answerable for their effects," a wise move on 
his part considering that the New London medicine contained 
mercury. The feud continued until the patents expired, and 
then resumed when each proprietor renewed, all the while
attracting more business from the attention they
• 25received.
In drug catalogues such as John Henshaw's of Boston,
the two medicines were distinguished as either the Windham
or New London brand. Others capitalized from the use of the
name Lee, while yet others copied the name Bilious Pills.
In 1797 Benjamin Duvall of Virginia patented an anti-bilious
pill, as did Thomas H. Fauson of Connecticut in 1802 and 
2 61803. Probably many other copies did not obtain a
patent, but sold well, such as Gregory's Bilious Pills
27listed m  an 1804 drug catalogue.
The successes and excesses of the patent medicine 
industry can often be contributed to the unique 
personalities of its entrepeneurs. One of the most unusual 
men and one of the most successful in the early nineteenth 
century was Thomas W. Dyott. Dyott was one of the first 
true industrialists in the patent medicine business, with 
factories centered in Philadelphia. His company's origins 
were in patent medicines, and although the emphasis remained 
so, he diversified to include the production and sale of
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glass, garden seeds, paints, dyer's supplies, chemical and
pharmaceutical apparatus, foodstuffs, and cowskin whips.
Dyott1s ads filled the pages of the Aurora, the Democratic
Press, and many other newspapers, advertising his "approved
family medicines which are celebrated for the cure of most
diseases." Dyott was the sole proprietor of the medicines,
but he had agents in New York, New Orleans, Cincinnati, and
other parts of the country to distribute his products
nationwide. As if a predecessor of McDonald's, Dyott's
bottles and boxes announced a million persons cured by his 
2 8nostrums.
Dyott, an English immigrant, had opened a shoe cleaning
and polishing shop, manufacturing his own liquid
shoeblacking, an ominous beginning for preparing patent
medicines that some claimed were as effective on diseases as
shoe polish. His business was apparently successful enough
to allow him to open his own drug store selling medicines of
his own manufacture. The next several decades saw Dyott's
operation expand so that by 1820 he founded Dyotsville, a
company town complete with library, concerts, lecture, and a 
29hospital.
Dyott's operation expanded at this time to include his 
own glassworks. His research and experimentation improved 
the quality of bottle glass and lowered its price 
considerably in the United States. The advantage was of 
course that he gained his own supply of bottles for his 
medicines, but he also produced counterfeit bottles for the
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old English patent medicines. This action severed the last
tie with imported English medicines. Though the formulas
had been copied in America for years, the bottles were still
often imported from England. When Dyott was able to
decrease the price of the bottles by over $3.00, the English
imports were d o o m e d . ^
Dyott's empire ended with the Panic of 1837. Dyott's
Manual Labor Bank, which he had created for his employees,
had gone under in the economic crisis. Audits revealed
embezzlement, and Dyott was jailed. The final chapter of
Dyott's story, however, was a triumphant comeback after his
31release. In 1861, Thomas Dyott died a wealthy man.
Competing with Dyott were hundreds of smaller firms
across the country. They started, like Dyott, as single-man
operations selling a few assorted medicines. Most lasted
only a short time, but some weathered the viciously
competitive market, some even into the twentieth century.
In 1795 Dr. Isaac Thompson of New London, Connecticut first
offered his nostrum Dr. Isaac Thompson's Celebrated Eye
Water. In 1830 he sold his formula to his son-in-law John
L. Thompson, who produced the medicine and sold it along
with other popular patent medicines. By the Civil War, John
L. Thompson Sons and Co. occupied a four-story building in
Troy, New York. In 1937 the company expanded to a
32neighboring building. Another success story is that of 
Jeremiah Curtis and Son. In 1835 the parent company of 
Curtis and Perkins was manufacturing Mrs. Winslows Soothing
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Syrup. "Used in season, never fails to cure all diseases
with which children are affected during the process of
teething." The firm moved to New York several years later.
In 1942 the medicine was still being produced and sold from
33offices m  the Empire State Building.
Two further developments grew out of this early
American period of patent medicines that would affect the
industry throughout the nineteenth and into the twentieth
century. Most important to the quality of drugs and
nostrums was the first attempts at professionalization and
standardization. The movement came, appropriately, from
Philadelphia which had become the center of the large
American drug and medicine trade. The Philadelphia College
of Pharmacy realized that "the great body of practitioners,
especially those residing in the country, knowing medicines
only by their names, have been ignorant of the very
different qualities subsisting among them. In their
purchases, incapable of making a selection as to quality,
the lowest price was preferred." In response the College
intended to establish standards for the apothecary, teach
the rudiments of the field, and present some type of
34distinguishing accreditation.
In 1821 the college created a Master of Pharmacy 
degree. The college required candidates for the degree to 
have served a three-year apprenticeship under a respectable 
apothecary, to prove good moral character, and to attend two 
courses of lectures on chemistry, materia medica, and
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pharmacy. The act met with stiff opposition from many who 
felt it was an attempt to drive them out of business,
especially since it would require a fee of $10.00 or $15.00
35to graduate. The college and its degree did little at 
first to suppress the quackery rampant in patent medicines, 
but it did set an important precedent for quality and 
professionalism.
Of more immediate effect on the patent medicine 
industry was the college's attempt to standardize the
 ^ <5
formulas for eight of the old English patent medicines which/
were still sold in the United States, but had been altered
in their preparation. The committee assigned to this task
found their collection of recipes to "differ so much from
each other, as to render a reformation in the formulae
absolutely necessary and the task of reformation a very
difficult one. In some of the recipes for the same
medicine, for instance, there are not two articles alike,
and the quantity of opium in the Bateman's drops varies from
one to nearly fourteen parts in a thousand parts of the 
3 6liquid." They also determined that the original 
specifications of the medicines listed at the Office of 
Rolls in London, served only to mislead possible 
counterfeiters, so the committee set about to standardize 
the formulas to meet as closely as possible their claims./
The resulting pamphlet was reprinted several times, and no 
doubt served as a valuable guide to many preparators of 
Hooper's, Turlington's, Anderson's and the other medicines.
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The second important development in the 1790s and early
1800s affected the quantity of patent medicines. To all the
factors discussed in Chapter One for the success of patent
medicines must be added the country's westward expansion and
growing population. As the population moved westward, so
did the demand for patent medicines. Thomas W. Dyott's
advertisements in the 1820s and 1830s evoked this opening
market. Pictured being loaded in front of his Philadelphia
factory was a Conestoga wagon laden with his nostrums
37destined for the West.
Production naturally followed demand. To escape the v"
high costs of transportation, patent medicine firms appeared
throughout the West, away from the older centers of New York
and Philadelphia. In 1834 Thomas Bohannan and Co. of
Louisville, Kentucky sold nineteen different patent 
3 8medicines. Farther west, on the Missouri frontier was
the business of Dr. John Sappington. Sappington had become
renowned for his treatment of malaria with ground chinchona
bark (quinine). He was so successful that he began
large-scale production of his Fever Pills in 1832. Twelve
39years later he was producing 500,000 boxes a year.
By 1840 the American patent medicine industry lay on 
the verge of the explosive growth that characterize it 
today. As for the industry's English origins, "the trade 
had gone full circle" notes historian John Camp, "and many 
American specialties were being exported to Britain.
Contrary to the practise a century before, English
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manufacturers were now making their own medicines and giving
40them American names." Throughout the century, better
transportation developed, medical knowledge grew, population
increased, and American society developed, changing the
marketing and production of patent medicines. Yet the
industry's general form was always based on its eighteenth-
and early nineteenth-century antecedents. In November 1906
the Bureau of Chemistry of the Department of Agriculture was
reminded how close the industry was to its origins. The
Bureau received a letter from a wholesale druggist in
Evansville, Indiana. One of the remedies in his stock was
Godfrey's Cordial. Because it contained opium, he wanted to
know what he was required to do under the provisions of the
41new Pure Food and Drug Act. The original Godfrey's 
Cordial had been patented in London in 1721.
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APPENDIX A
The following is a list of formulas for some eighteenth 
and early nineteenth century patent medicines. In some 
cases, there are several different formulas listed. These 
only begin to suggest the great variety of products that 
were bottled under the same name. It is probable that 
formulas varied between lots made by the same manufacturer. 
What does remain relatively constant, though, are the types 
of ingredients used. This list is a glimpse of the types of 
early patent medicines being consumed by Americans in the 
early years of the industry. The source follows each 
f ormula.
Anderson * s Pills; 1. Barbadoes aloes 1 o z ., jalap 1/4
o z ., soap 1 dr., oil of aniseed 1/2 dr. tincture of aloes 
q.s.; mix, and divide into 4-grain pills.
2. Barbadoes aloes 5 o z ., water 1 
oz.; soften by the heat of a water-bath, and add powdered 
jalap, powdered aniseed, and ivory black, of each 1 oz., oil 
of aniseed 1 dr.
3. Barbadoes aloes 16 oz., black 
hellebore, jalap, sucbarvonate of potash, of each 1 oz., oil 
of aniseed 1/2 o z ., syrup of buckthorn q.s. to form a mass. 
To be divided into 4-grain pills.
4. Barbadoes aloes 24 oz., soap 4 
oz., colocynth 1 oz., gamboge 1 oz., oil of aniseed 1/2 
fluid oz., mix, and divide into pills of 3 g r . each.
(From The Druggist1s General Receipt Book, 1850, Lloyd 
Library and Museum)
Ball's Purging Vermifuge Powder; Ball's purging 
vermifuge powder is a very powerful medicine. It is made of 
equal parts of rhubarb, scammony, and calomel, with as much 
double refined sugar as is equal to the weight of all the 
other ingredients. These must be well mixed together, and 
reduced to a fine powder. The dose for a child is from ten 
grains to twenty, once or twice a week. An adult may take a 
dram for a dose. (From William Buchanan, Domestic Medicine, 
London, 1772)
Bateman's Pectoral Drops: 1. Compound spirit of aniseed 16
fluid ounces, opium 1 dr., camphor 1 dr., oil of fennel 20 
drops, cochineal 2 dr.
2. Proof spirit 4 gal., red 
saunders 2 oz.; digest 24 hours, filter, and add powdered 
opium 2 oz., camphor 2 o z ., catechu 2 oz., oil of aniseed 4 
fluid drachms.
(From The Druggist1s General Receipt Book)
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Daffy1s Elixir: Take of the best senna, guaiacum, 
liquorice sliced small aniseeds, coriander seeds, and 
elecampane-root, of each half an ounce; raisins of the sun, 
stoned, a quarter of pound: let them all be bruised and put 
into a quart of the best brandy. Let it stand by the fire a 
few days, and then strain it.
(From John Wesley, Primitive Remedies, London, 1776)
Another Receipt for Daffy's Elixir: Take of senna 
leaves, two ounces coriander-seeds, a quarter of an ounce? 
proof spirit, or brandy, three pints: put all the 
ingredients into a bottle for four or five days, shaking it 
frequently; strain off the tincture, and add three ounces of 
powdered sugar candy. This medicine is more active than the 
preceding, and is calculated to remove obstructions in the 
bowels, in cholics and other complaints that require 
purging, especially when castor oil has not the desired 
effect. The dose is one, two or three table spoonsful, in a 
cup of camomile tea, or water.
(From John Wesley, Primitive Remedies, London, 1776)
Daffy1s Elixir: This is similar to the compound 
tincture of senna; but different makers have their peculiar 
formulea. The following are some of them. Avoidrupois 
weight seems to be intended.
1. Senna leaves 3 3/4 lb, jalap aniseed, caraway seed, 
of each 20 oz., rectified spirit 18 pints, sugar 5 lb.
Infuse the senna 2 or 3 times in sufficient boiling water to 
yield, when strained with pressure, 4 gallons in the whole. 
Add to this the tincture made with jalap and seeds, digested 
with the spirit for a week. Pour off the clear liquor, and 
add the sugar, and brandy colouring if required.
(From The Druggist's General Receipt Book, 1850)
Dalby1s Carminative: 1. Carbonate of magnesia 1 oz.,
syrup of poppies 5 oz., tincture of wood-soot 1 oz., oil of 
caraway 25 drops, oil of peppermint 16 drops, water and 
spirit of wine, each 1/2 oz. Mix.
2. Carbonate of magnesia 2 
scruples, oil of peppermint 1 drop, oil of nutmeg 2 drops, 
oil of aniseed 3 drops, tincture of castor 30 drops,
tincture of assafoetida 15 drops, tincture of opium 5 drops,
spirit of pennyroyal 15 drops, compound tincture of cardamom
30 drops, peppermint water 2 oz. Mix.
3. Water 10 lb. white sugar 32 
oz., tincture of opium 6 fluid oz., oil of peppermint, 
caraway, and fennel, of each 40 minims. Mix.
(From The Druggist's General Receipt Book, 1850)
L e e 1s Antibilious Pills: Aloes 12 oz., scammony 6 o z .,
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gamboge 4 oz., jalap 3 oz., calomel 5 oz., soap 1 o z ., syrup 
of buckthorn 1 oz., mucilage 7 oz.; mix, and divide into 
5-grain pills.
(From The Druggist's General Receipt Book, 1850)
D r . Stephen1s Cordiall Water: "Take a gallon of ye best
gascoyne wine, then take cloves, ginger, galling gall, 
cinnamon & nutmeggs graynes, anny seeds, fennell seeds, 
carraway seeds, of each a dram, then take wild time, 
lavender, sag-mints, hysope, red roses, garden time, 
pellitory of ye wall & rosemary of each one handful, bray 
the hearbs small and stamp ye spices all together very small 
& put into your wine and cover it, close for 12 hours except 
when your stir it which must be often, distill it in a 
Linbeck and keep ye first water by its selfe it beeing ye 
strongest, but of ye second sort may drink A greater 
quantity."
(From Frances Parke Custis Cook Book, Colonial Williamsburg 
Foundation Library)
Stoughton's Elixir; 1. Gentian 36 oz., serpentary 16
oz., dried orange peel 24 oz., calamus aromaticus 4 oz., 
rectified spirit and water, of each 6 gallons old measure.
2. Genetian 4 lb, orange peel 2 lb, 
cardamom seed 1 oz., rectified spirit 8 gallons.
(From The Druggist1s General Receipt Book, 1850)
Turlington1s Balsam; Take balsams of Peru and Tolu, of 
each half an ounce; gum storax, in tears, and gum guaiacum, 
of each one ounce; gum benjamin, an ounce and a half; 
hepatic aloes and frankincense, of each two drachms: let the 
gum be bruised, and put all the ingredients into a quart of 
rectified spirits of wine; shake the bottle frequently, and 
in eight days it is fit for use. This is indeed a most 
excellent medicine for man or beast, or for any fresh wound. 
(From Primitive Medicine)
Turlington1s Balsam: Rectified spirit 8 old wine pints, 
bensoin 12 oz., liquid styrax 4 oz., socotrine aloes 1 o z ., 
balsam of Peru 2 oz., myrrh 1 o z ., angelica root 1/2 oz., 
balsam of tolu 4 oz., extract of liquorice 4 oz., make a 
tincture.
(From The Druggist's General Receipt Book, 1850)
Turner1s Cerate: Turner's cerate may be prepared by 
dissolving half a pound of yellow wax in an English pint of 
olive oil,, over a slow fire. As the mixture cools, and 
begins to grow stiff, half a pound of calamine prepared must 
be sprinkled into it keeping constantly stirring them 
together till the cerate is grown quite cold.
(From Domestic Medicine)
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APPENDIX B
Patent Medicines Available in Williamsburg 
and Date of First Availability:
1737
Anderson's Pills 
Bateman's Drops 
Squire's Elixir
1745
Daffy's Elixir 
Lockyer's Pills 
Stoughton's Elixir
1746
Bostock's Elixir 
Eaton's Balsamic 
Raleigh's Cordial 
Stoughton's Drops
1751
Eaton's Styptic 
Freeman's Cordial 
Glauber's Salts 
Godfrey's Cordial 
Helvetius' Styptics 
Turlington's Balsam of Life 
Tur1ington's Drops
1755
Bostock's Cordial
1759
Fraunce's Female Strengthening Elixir
Greenough's Tincture
Dr. James' Fever Powders
1761
Daffy's Grand Elixir
1767
Bostock's Purging Elixirs
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Daffy's Purging Elixir 
Hill's Essence of WaterdocK 
Hill's Tincture of Valerian 
Mrs. Rednap's Fit Drops 
Stoughton's Bitters 
Ward's Red Pills 
Ward's Essence For Headache 
Ward's White Drops
1768
Bateman's Pectoral Drops 
Blackrie's Lixivium 
Friar 1s Balsam 
Hill's Bardana Drops 
Hill's Elixir Bardana 
Hill's Goldenrod 
Hooper's Female Pills 
Pitt's Bitters 
Walker's Jesuit Drops
1769
Hill's Pectoral Balsam of Honey 
Perkin's Specific Dentifrice 
Trueman's Cordials
1770
Bateman's Golden and Plain Spirits of Scurvy Grass
Betton's British Oil
Dr. Bolderson's Worm Cakes
Chase's Balsamic Pills
Madden's Oil
Madden's Foreign Oil
Madden's Sovereign Oil
Radcliffe's Elixir
Stoughton's Stomachic Elixir
Swinsen's Electuary for Stone and Gravel
1771
Hemet's Essence of Pearl Powder 
Pike's Ointment For Itch
1772
Bateman's Antimonial Drops 
Dutton's Corn Salve 
Fit Drops
Jesuit's Antimonial Drops 
Keyser ' s Pills
Dr. Norris' Antimonial Drops
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1773
Fraunce's Female Pills 
Pugh's Famous Eye Water
1774
Brinkwell's Purging Elixir Of Peppermint 
Hill's Balsam of Honey 
Hill's Tincture of Goldenrod
1775
Maredant's Anti Scorbutic Drops
1778
Dr. Baker's Dentifrice
Ryan's Worm Destroying Sugar Plums
1779
Dickinson's Drops 
Hammond's Antimonial Essence 
Hammond's Specific Pills
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